Haem: Blood Tranfusions 2 Flashcards

1
Q

What is the difference between acute and delayed transfusion reactions?

A

Acute < 24 hours

Delayed > 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List some causes of acute transfusion reactions.

A
  • Acute haemolytic (ABO incompatibility)
  • Allergic/anaphylaxis
  • Infection (bacterial)
  • Febrile non-haemolytic
  • Respiratory (TACO and TRALI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List some causes of delayed transfusion reactions.

A
  • Delayed haemolytic transfusion reaction
  • Infection (viral, malaria, vCJD)
  • TA-GvHD
  • Post-transfusion purura
  • Iron overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most common transfusion reaction?

A

Transplant-associated circulatory overload (TACO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some early features that might be suggestive of acute transfusion reaction?

A
  • Rise in temperature or pulse
  • Fall in BP

NOTE: these can occur before the patient experiences any symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List some symptoms of an acute transfusion reaction.

A
  • Fever
  • Rigors
  • Flushing
  • Vomiting
  • Dyspnoea
  • Pain at transfusion site
  • Collapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If the patient is unconscious, how might you detect an early transfusion reaction?

A
  • Baseline temperature, pulse, RR and BP before transfusion
  • Repeat every 15 mins (most reactions start within 15 mins)
  • Repeat hourly and at the end of the transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the clinical features of a febrile non-haemolytic transfusion reaction?

A
  • Occurs during/soon after transfusion (of blood or platelets)
  • Rise in temperature, chills and rigors

NOTE: this used to be common before blood was leucodepleted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What causes febrile non-haemolytic transfusion reactions?

A

Release of cytokines from white cell during storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is febrile non-haemolytic transfusion reaction treated?

A

Slow/stop the transfusion and treated with paracetamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the clinical features of an allergic transfusion reaction.

A
  • Mild urticarial or itchy rash
  • Sometimes causes a wheeze
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is an allergic transfusion reaction managed?

A
  • Stop or slow the transfusion
  • IV antihistamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What usually causes allergic transfusion reactions?

A

Allergy to plasma protein in the donor

NOTE: it is more common in patients with a history of atopic disease and it may not recur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which blood product is most likely to cause an allergic transfusion reaction?

A

Plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List some symptoms of an acute haemolytic transfusion reaction.

A
  • Chest/loin pain
  • Fever
  • Vomiting
  • Flushing
  • Collapse
  • Haemoglobinuria
  • Low BP
  • High HR
  • High Temp
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In an acute haemolytic transfusion reaction, why is it important to take a blood sample?

A

Send for FBC, biochemistry, coagulation, repeat X-match and DAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does bacterial contamination from donated blood products present?

A

Similarly to ABO mismatch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What causes bacterial infection from donated blood products?

A
  • Bacteria can produce an endotoxin that causes immediate collapse
  • The bacteria could have come from the donor or from the processing of blood products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

List blood products in order of likelihood of getting contaminated?

A
  • Platelets (MOST LIKELY)
  • RBCs
  • Plasma (least likely)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What measures can be taken to reduce the likelihood of bacterial contamination?

A
  • Donor questioning
  • Arm cleaning
  • Diversion of first 20 mL into a pouch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the storage and shelf-life of RBCs.

A
  • Stored in a 4 degree fridge for 35 days
  • If it is kept out for > 30 mins it cannot go back in the fridge
  • Complete transfusion must take place within 4.5 hours of leaving the fridge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the storage and shelf-life of platelets.

A

Stored at 22 degrees for 7 days

NOTE: they are screened for bacteria before relase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the clinical features you would expect to see in an anaphylactic reaction to blood products.

A
  • Occurs soon after starting transfusion
  • Drop in BP
  • Rise in HR
  • Very breathless with a wheeze
  • Laryngeal or facial oedema

NOTE: it is caused by IgE-mediated mast cell degranulation

NOTE: most allergic reactions are not this severe

24
Q

Which patient group is more likely to have severe allergic reactions to blood products?

A

IgA deficient patients (anti-IgA antibodies may develop in response to exposure to IgA in donor’s blood)

25
Q

What causes TACO and what are the main clinical features?

A
  • Usually caused by a lack of attention to fluid balance (especially in cardiac failure, hypoalbuminaemia, extremes of age)
  • Leads to pulmonary oedema
  • SOB
  • Low oxygen saturations
  • High HR
  • High BP

NOTE: this is very common

26
Q

What are the CXR features of TACO?

A

Fluid overload

Cardiac failure

27
Q

What are the main clinical features of TRALI?

A
  • Looks like ARDS
  • SOB
  • Drop in oxygen saturation
  • Rise in HR
  • Rise in BP
28
Q

What CXR features would you expect to see in TRALI?

A

Bilateral pulmonary infiltrates within 6 hours of transfusion due to circuloatry overload and other causes.

29
Q

Outline the mechanism of TRALI.

A
  • Anti-WBC antibodies in donor blood interact with WBC in the patient
  • Aggregates of WBCs get stuck to pulmonary capillaries resulting in the release of neutrophil proteolytic enzymes and toxic oxygen metabolites
  • This leads to lung damage
30
Q

What are the main differences between TACO and TRALI?

A

JVP is not raised and the patient will not respond to frusemide in TRALI

31
Q

How can TRALI be avoided?

A

Using male donors (haven’t been pregnant) who haven’t had a transplant so they will not have produced antibodies against HLA

32
Q

What is alloimmunisation?

A

The process of developing antibodies against an antigen

NOTE: 1-3% of people receiving transfusions will develop antibodies against an RBC antigen that they lack

33
Q

What are the consequences of alloimmunisation with regards to blood transfusions?

A

Repeat transfusion with blood containing the antigen will lead to extravascular haemolysis

This is IgG mediated so will take 5-10 days

34
Q

What are the typical blood test results you expect to see during a haemolytic episode?

A
  • High bilirubin
  • Low haemoglobin
  • High reticulocytes
  • Haemoglobinuria (for a few days until haemolysis stops)

NOTE: U&E should be tested to check for renal failure. Also group and screen should be repeated to check for the development of new antibodies

35
Q

In which patient groups is CMV dangerous?

A
  • Very immunosuppressed (e.g. SCT)
  • Pregnant women
  • Neonates
36
Q

What is the dangerous effect of parvovirus infection?

A

Causes temporary red cell aplasia

37
Q

Which patients are most affected by parvovirus infection?

A
  • Foetuses
  • Patients with haemolytic anaeamis (e.g. sickle cell disease)
38
Q

What precaution can be made by blood donation services to prevent transmission of vCJD?

A

Blood services exclude people who have had transfusions in the past as donors.

39
Q

Describe the mechanism of transfusion-assocaited Graft-versus-Host disease.

A
  • Donor blood will contain some lymphocytes that are capable of dividing
  • Normally, the patient’s immune system will recognise and destroy these foreign lymphocytes
  • In susceptible patients (very immunosuppressd), the lymphocytes are not destroyed
  • They begin to recognise patient HLA as foreign and begins attacking it (damages the gut, liver, skin and bone marrow)

NOTE: this is always fatal

40
Q

What are the clinical manifestations of transfusion-associated Graft-versus-Host disease?

A
  • Diarrhoea
  • Liver failure
  • Skin desquamation
  • Bone marrow failure
  • Death (weeks to months)
41
Q

How can transfusion-associated Graft-versus-Host disease be prevented?

A

Irradiate blood components for very immunocompromised patients

42
Q

At what point after transfusion does post-transfusion purpura happen?

A

7-10 days after transfusion of platelets or red blood cells

NOTE: it usually resolves in 1-4 weeks but can cause life-threatening bleeding

43
Q

Which patient group tends to be affected by post-transfusion purpura?

A

HPA-1a negative patients who have previously been immunised by pregnancy or transfusion

44
Q

How is post-transfusion purpura treated?

A

IVIG

45
Q

How much iron is there in a unit of blood?

A

200-250 mg

46
Q

How can iron overload be prevented?

A

Iron chelators (e.g. exjade)

47
Q

What is haemolytic disease of the newborn?

A

Anaemia and high bilirubin in the newborn

NOTE: the bilirubin builds up in the newborn after birth because they no longer have a placenta to remove it

48
Q

When should all women have a group and screen during pregnancy?

A

12 weeks

28 weeks

49
Q

If anti-D antibodies are detected in a pregnant women, what further steps should be taken?

A
  • Check if the father has the antigen
  • Monitor the level of antibody
  • Check cffDNA
  • Monitor foetus for signs of anaemia (MCA Doppler Ultrasound)
  • Deliver the baby early because it gets a lot worse around term
50
Q

What intervention may be performed if the foetus is found to be very anaemic?

A

Intrauterine transfusion into the umbilical vein

NOTE: anti-D is the most important antibody for causing haemolytic disease of the newborn

51
Q

How can haemolytic disease of the newborn be prevented?

A
  • If an RhD-negative woman of childbearing age needs a blood transfusion, always use RhD-negative blood
  • IM anti-D immunoglobulin can be given at times of possible sensitising events

NOTE: for anti-D immunoglobulin to be effective, it needs to be given within 72 hours of a sensitising event and it does not work if the mother has already developing anti-D antibodies

52
Q

Outline the mechanism of action of anti-D immunoglobulin.

A
  • RhD-positive cells of the foetus get coated by exogenous anti-D
  • These will then be removed by the mother’s reticuloendothelial system (spleen) before they can sensitise the mother’s immune system
53
Q

List some occasions in which anti-D immunoglobulin should be given.

A
  • At devliery if the baby is found to be RhD-positive
  • Spontaneous miscarriages if surgical evacuation was needed
  • Surgical termination of pregnancy
  • Amniocentesis and chorionic villous sampling
  • Abdominal trauma
  • External cephalic version
  • Stillbirth or intrauterine death
54
Q

What doses of anti-D tend to be given?

A

Less than 20 weeks = 250 iU

More than 20 weeks = 500 iU

55
Q

Which test is done if a sensitising event occurs >20 weeks to determine if more anti-D is needed?

A

Kleihauer test

56
Q

When should anti-D be routinely given to RhD-negative women?

A

Usually 500 iU at 28 weeks and 34 weeks

NOTE: can also be 1500 iU at 28-30 weeks

57
Q

List some other antibodies (aside from RhD) that can cause haemolytic disease of the newborn.

A
  • Anti-c and anti-Kell can cause severe HDN (less severe than RhD)
  • Anti-Kell causes haemolysis and reticulocytopaenia in the foetus
  • IgG anti-A and anti-B can cause mild HDN in group O mothers (usually treated with phototherapy)